Skip to main content

Table 4 Neonatal outcomes studied by indication of oocyte donation treatment compared to spontaneously conceived infants (Comparison group A)

From: Neonatal outcomes in pregnancies resulting from oocyte donation: a cohort study in Sweden

 

Comparison group A(CgA)

“Diminished ovarian reserve” subgroup (DOR)

”OD other” subgroup (ODo)

p-value CgA vs DOR

p-value Cga vs ODo

 

n

(%)

n

(%)

n

(%)

  

Congenital malformation

5/139

3.6 %

3/35

8.6 %

1/32

3.1 %

0.202

1.000

1 min Apgar s <7

9/149

6 %

5/36

13.9 %

4/34

11.8 %

0.110

0.266

5 min Apgar s <7

1/149

0.7 %

3/36

8.3 %

2/34

5.9 %

0.024

0.089

10 min Apgar s <7

0/148

0/36

1/34

2.9 %

0.187

Preterm delivery (<37w)

12/149

8.1 %

6/37

16.2 %

6/34

17.6 %

0.133

0.090

SGA diagnosis

3/149

2 %

1/36

2.8 %

5/34

14.7 %

0.583

0.006

 

Median (IQR)

Range

Median (IQR)

Range

Median (IQR)

Range

  

Head circumference

35 (2)

25–40

35 (2.75)

30–38

34.5 (4)

27–38

0.792

0.107

Birthweight

3472.5 (704)

730–5800

3550 (913)

2005–4910

3080 (801)

1105–4670

0.458

0.004

Birthweight term infants

3512 (668)

2200–5800

3622.5 (931.3)

2720–4910

3270 (686)

2284–4670

0.898

0.034

Birth Length

51 (3)

32–56

50 (5)

45–54

49 (3.25)

39–54

0.662

0.001

Birth length term infants

51 (3)

42–56

51 (4.25)

45–54

50 (2.75)

45–54

0.832

0.011

  1. “Diminished ovarian reserve” subgroup includes women with Premature Ovarian Insufficiency (POI) or those who are poor responders
  2. ”OD other” subgroup includes all other indications (i.e. women with Turner syndrome, after oophorectomy or chemotherapy, genetic reasons, multiple unsuccessful IVF, ”egg factor”)